Table 1.
Change in follow-up status following review at pre-follow-up multidisciplinary team
| Allocated to Group 1 follow-up without pre-FU MDT | Allocated to Group 2 follow-up without pre-FU MDT | Patients requiring no follow-up without pre-FU MDT | Non-COVID-19 6/52 CXRs without pre-FU MDT | Indeterminate CXRs without pre-FU MDT | Total | |
|---|---|---|---|---|---|---|
| Allocated to Group 1 follow-up with pre-FU MDT | 25 | 1 | 0 | 0 | 1 | 27 |
| Allocated to Group 2 follow-up with pre-FU MDT | 2 | 44 | 3 | 0 | 38 | 87 |
| Patients requiring no follow-up with pre-FU MDT | 5 | 12 | 16 | 6 | 150 | 189 |
| Non-COVID-19 6/52 CXRs with pre-FU MDT | 3 | 8 | 1 | 1 | 65 | 78 |
| Non-COVID-19 bespoke follow-up with pre-FU MDT a | 0 | 3 | 0 | 1 | 7 | 11 |
| Total | 35 | 68 | 20 | 8 | 261 | 392a |
aNon-COVID-19 bespoke follow-up refers to non-COVID-19 respiratory follow-up eg review in pleural clinic. CXRs = chest X-rays; FU = follow-up; MDT = multidisciplinary team.